



















A Guide To 
The Hanford Thyroid 
Disease Study 




Following more than 12 years of scientific research, the Centers for 
Disease Control and Prevention (CDC) and the Fred Hutchinson Cancer 
Research Center have released the Hanford Thyroid Disease Study 
(HTDS) Final Report. 
The HTDS, mandated by Congress in 1988, was conducted to determine 
whether thyroid disease is increased among people who were exposed as 
children to atmospheric releases of radioactive iodine from the Hanford 
Nuclear Site (Hanford) in Washington State from 1944 through 1957.  
CDC and the Fred Hutchinson Cancer Research Center prepared this 
guide to help communicate the meaning of the HTDS to the public. 
The guide summarizes the findings, explains how and why the study 
was conducted, and includes information about the treatment of 
thyroid disease. 
In the mid-1980s, the U.S. Department of Energy released documents 
showing that large amounts of radioactive materials, including iodine-131, 
had been released into the environment from Hanford since the mid-1940s. 
The public, health officials and scientists were concerned that these 
materials could have harmed the health of people living in the region. 
The HTDS was conducted in response to these concerns. While no 
study can determine the cause of an individual case of thyroid disease, 
an epidemiological study, such as the HTDS, provides the best way to 
determine whether disease has increased in a population exposed to a 
potentially harmful agent such as radiation. 
Over the years, many thousands of people have been involved in the 
HTDS, including the 3,440 participants of the study.  Members of the 
public, health care officials, physicians, scientists and many others have 
also been involved. 
CDC remains committed to providing useful information to the public 
about the HTDS and related issues. Please refer to page 22 of this guide 











































ABOUT THE HANFORD 
THYROID DISEASE STUDY 
The Hanford Thyroid Disease Study 
(HTDS) is a scientific study conducted 
to determine whether the risk of
thyroid disease is increased among 
people exposed to radioactive iodine 
(iodine-131) from the Hanford 
Nuclear Site in Washington from 
1944 through 1957. 
The question was:
“Did exposure to iodine-131 
result in increased incidence of
thyroid disease?” 
Study Focus — Iodine-131 was the 
primary source of radiation for 
many people exposed to Hanford’s 
radiation releases. Since iodine-131 
concentrates in the thyroid gland 
when it is inhaled or consumed in 
contaminated food, the HTDS 
focused on thyroid disease. 
Research Team — The HTDS was 
managed by the Centers for Disease 
Control and Prevention (CDC), an 
agency in the U.S. Department of 
Health and Human Services.  The 
Fred Hutchinson Cancer Research 
Center in Seattle, Washington
conducted the scientific and technical 
work.  The HTDS Final Report was 
released in June 2002. 
WHAT HAPPENED 

AT HANFORD (see page 2)
 
The Hanford Nuclear Site was built in 
the 1940s in southeastern Washington 
State to produce plutonium for nuclear 
weapons.
In the mid 1980s, as a result of
public requests, the U.S. Department 
of Energy released previously
unavailable or classified documents 
about past operations at Hanford.  The 
information showed that large 
amounts of iodine-131 and other 
radioactive materials were released 
into the air from Hanford from 1944 
through 1957. 
Concerns about the possible health 
effects of Hanford’s radiation led to a 
decision by Congress to mandate 




HOW WERE PEOPLE EXPOSED 
TO IODINE-131 FROM HANFORD? 
People were Iodine-131 
exposed concentrates in 






HOW THE STUDY WAS 

CONDUCTED (see page 6)
 
To study the health effects of Hanford’s 
iodine-131, researchers investigated 
a group of people with a wide range 
of radiation doses to the thyroid.  In 
this way, researchers could compare 
groups of people with similar 
characteristics (such as lifestyle and 
diet) but different levels of exposure. 
Participant Selection — Other studies  
suggest that young children may be 
the most susceptible to the effects
of radiation on the thyroid gland. 
Therefore, the HTDS selected
participants who were young children 
when Hanford releases of iodine-131 
were highest.  Scientists also ensured 
that the HTDS participants included 
many people who lived in areas 
around Hanford where the highest 
thyroid radiation doses occurred.
From a sampling of 5,199 birth 
records, scientists were able to 
locate 3,440 people who were both 
willing to participate and able
to provide the necessary data for 
evaluation of thyroid disease.  
Data Collection — Participants underwent 
complete evaluations for thyroid disease, 
and provided detailed information 
about the places they lived and the 
quantities and sources of the food 
and milk they consumed. 
Data Analysis — For each type of 
thyroid disease, the research team 
examined how the rates of disease 
varied in relation to participants’ 
estimated radiation doses from 
Hanford’s iodine-131. 

































FINDINGS (see page 9) 
The HTDS data show that the risk of 
thyroid disease was about the same 
regardless of the radiation doses 
people received from Hanford.  In 
other words, no associations between 
Hanford’s iodine-131 and thyroid 
disease were observed. 
> Researchers studied all types 
of thyroid disease, a disease of 
the parathyroid glands, and 
abnormalities of the thyroid
gland that can be seen on
ultrasound examinations.  
> The percentages of people with 
each kind of thyroid disease or 
with ultrasound abnormalities 
were about the same regardless of 
their estimated radiation dose 
from Hanford’s iodine-131.
The findings do not prove that 
Hanford radiation had no effect on 
the health of the area population. 
However, they show that if there
is an increased risk of thyroid 
disease from exposure to Hanford’s 
iodine-131, it is probably too small to 
observe using the best epidemiologic 
methods available. 
Thyroid disease was found in the 
study population.  This was expected 
because thyroid disease is common 
in other populations, especially 
among older people and women.
Based on a review of other studies, 
researchers found that the rates 
of thyroid disease in the HTDS 
population were generally consistent 




REVIEW (see page 18) 
CDC formed a committee of scientists 
and members of the public to advise 
CDC on the design and implementation 
of the study.  Members of the public 
and public interest groups provided 
input in public meetings and written 
comments to CDC throughout the study. 
At the request of CDC, the National 
Academy of Sciences peer reviewed 
the HTDS at key points in the study. 
Peer review is an independent 
analysis of a study that provides 
confidence that the correct methods 
are being used. 
ABOUT THYROID 

DISEASE (see page 20)
 
The thyroid gland is located at the 
base of the neck (see figure below). 
Thyroid disease is common in the 
general population.  Thyroid disease 
includes functional disorders and 
abnormal growth in the gland, 
including cancer.  Most thyroid 
problems can be detected and treated. 
If you are concerned about exposure 
to iodine-131 from Hanford or
experience thyroid disease symptoms, 
you are encouraged to see your 





The thyroid gland is butterfly-shaped, with two lobes about the size of teaspoons.
It is located in the front of the neck, below the Adam’s apple. 
Thyroid Gland, Right Lobe 
Trachea 
Thyroid Gland, Left Lobe 
Thyroid Cartilage 
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A Brief History 
of Hanford 
>	 About the Hanford
Nuclear Site 
>	 Exposures to Radiation 
>	 Classified Information 
Released 
>	 Why the HTDS 
Was Conducted 
SECTION SUMMARY 
> From 1944 through 1957, large 
amounts of radioactive materials 
were released into the atmosphere 
at Hanford. 
> Milk consumption was the major way 
most people were exposed to Hanford’s 
iodine-131. 
> Public concern led to the release of 
previously classified information 
about Hanford’s operations. 
> No other studies are directly 
comparable to the Hanford situation. 
ABOUT THE HANFORD 
NUCLEAR SITE 
The Hanford Nuclear Site occupies 
about 560 square miles in 
southeastern Washington State, 
adjacent to the towns of Pasco, 
Kennewick and Richland. The 
facility was the world’s first 
large-scale nuclear production 
plant. It was constructed in the 
early 1940s as part of the 
Manhattan Project to produce 
plutonium for nuclear weapons. 
Over the course of many years, 
large amounts of radioactive 
materials (radionuclides) were 
released into the atmosphere and 
the Columbia River as part of the 
plutonium production process. 
The major radioactive releases 
occurred in the form of gases and 
particles into the air from 1944 
through 1957. These releases 
occurred mainly because of 
increased production and lack of 
filter systems. Changes in the 
production process over the years 
greatly reduced releases into the air. 
Many different kinds of radioactive 
materials were released. For 
many people living in the region, 
most of their dose was due to 
iodine-131 released into the air. 
EXPOSURES TO RADIATION 
Iodine-131 was carried by winds 
to surrounding areas and deposited 
on vegetation. It was then 
absorbed in the milk of cows 
and goats that grazed on the 
contaminated vegetation. 
Drinking contaminated milk 
caused most of the radiation dose 
for most of the exposed people. 
People were also exposed by 
eating contaminated fruits and 




For a long time, details about 
Hanford’s operations were not 
public. In 1986, as a result of 
public concerns and requests 
made through the Freedom of 
Information Act, the U.S. 
Department of Energy (DOE) 
began releasing tens of thousands 




A Brief History 
of Hanford 
of pages of previously classified or 
unavailable documents.  
The documents revealed to the 
public, for the first time, that 
substantial quantities of 
radionuclides were released into 
the environment from Hanford. 
CDC convened a panel of 
independent scientists (Hanford 
Health Effects Review Panel) to 
evaluate the DOE documents. 
Two of the panel’s most important 
recommendations were to conduct 
a study to estimate the radioactive 
materials released from Hanford 
and to determine the feasibility of 
studying the health effects to the 
thyroid of that exposure. 
The panel’s recommendations 
evolved into what are known today 
as the Hanford Environmental 
Dose Reconstruction Project 
(HEDR) and the Hanford Thyroid 
Disease Study (HTDS). 
WHY THE HTDS 
WAS CONDUCTED 
The main reason why the HTDS 
was conducted is that the public, 
health officials and scientists were 
concerned about the possible health 
effects of Hanford’s radiation. 
Thyroid disease was a particular 
concern because iodine concentrates 
in the thyroid gland and the 
DOE documents showed that 
large amounts of iodine-131 were 
released from Hanford. In 
response to public concerns, 










HOW WERE PEOPLE EXPOSED TO IODINE-131 FROM HANFORD? 
Most people received most of their dose from contaminated milk. 
Iodine-131 Iodine-131 Cows and goats Iodine-131 passed Iodine-131 
released into air. was carried by grazed on the into cow’s and concentrates in 
winds and vegetation goat’s milk and the thyroid. 
deposited on contaminated by was consumed by 
vegetation, fruits iodine-131. area residents. 
and vegetables. 
People were also exposed by. . . 
eating contaminated fruits and vegetables. 











A Brief History 
of Hanford 
IN THE LATE 1980S, THE FEDERAL GOVERNMENT 
BEGAN TWO HANFORD-RELATED STUDIES 
Hanford Environmental 
Dose Reconstruction Project (HEDR) 
Purpose 
> Estimate type and amount of
radioactive materials released from 
Hanford. 
> Model how radioactive materials 
moved through the environment and 
food chain. 
> Develop computer software for 
estimating individual doses. 
> Estimate radiation doses to
representative individuals in the 
Hanford region. 
Conduct of the Study 
> Began in 1987; final report issued
in 1994. 
> The study was directed by an 
independent technical steering panel 
selected by deans of research 
universities in Washington and Oregon. 
> The study was conducted by Battelle 
Pacific Northwest Laboratories
originally under contract with the U.S. 
Department of Energy (DOE). 
Management responsibility was 
transferred to CDC in 1993. 
Hanford Thyroid 
Disease Study (HTDS) 
Purpose 
> Study the risk of thyroid disease 
among persons exposed to radioactive 
iodine-131 from Hanford. 
Conduct of the Study 
> Began in 1989; final report issued in 
2002. 
> Scientific and technical work were 
performed by the Fred Hutchinson 
Cancer Research Center under contract 
with CDC. 
> The research team used HEDR computer 
software together with information 
provided by HTDS participants to 
estimate individual radiation doses to 
the thyroid. 
Congress directed CDC to 
conduct a study of the effects of 
Hanford’s iodine-131 on thyroid 
disease. 
Many people ask, “Didn’t we 
already know that Hanford 
radiation causes thyroid disease?” 
Over the years, many studies of 
other populations have provided 
compelling reasons to suspect 
that the risk of thyroid disease 
might have increased in people 
who were exposed to Hanford’s 
iodine-131. 
Nevertheless, the published 
literature left room for doubt, 
since none of the studies examined 
circumstances quite like those of 
the Hanford experience. The 
following are ways other radiation 
studies are different from the 
Hanford situation: 
Type of radiation exposure – 
External irradiation by gamma 
rays (such as the atomic 
bombings in World War II) or 
x-rays used in medical treatments 
may have different effects than 
iodine-131. 
The people who were exposed – 
People who received iodine-131 
for treatment or diagnosis already 
had, or were likely to have, 
thyroid diseases, while people 
exposed to Hanford’s iodine-131 
were a general population, 
including some people with good 
health and some with poor health. 








A Brief History 
of Hanford 
How big the doses were – Doses of 
iodine-131 used for medical 
treatments are much higher than 
anyone is likely to have received 
from Hanford’s iodine-131. Doses 
from Chernobyl’s fallout were 
higher as well. 
External irradiation typically 
occurs within a few seconds or 
minutes. Medical exposures of 
iodine-131 typically occur over 
days to weeks. Exposure to 
How long people were exposed – 
Chernobyl’s fallout occurred from 
weeks to months. In contrast, 
many of those exposed to Hanford’s 
iodine-131 were exposed over a 
period of several years. 
Because other studies have 
addressed situations different 
from Hanford in important ways, 
it was necessary to study people 
who were actually exposed to 
Hanford’s iodine-131 in order to 
get the most reliable answer to 
the question of whether thyroid 
disease had been increased by 
Hanford’s iodine-131. 
No study can determine the 
cause of an individual case of 
thyroid disease. However, an 
epidemiological study, such as the 
HTDS, provides the best way to 
determine whether disease has 
increased in a population exposed 
to a potentially harmful agent such 
as radiation. ■ 
Scientists used computer software developed 
under the HEDR Project to estimate radiation 
doses to the thyroid that HTDS participants 






The HEDR Study Area constitutes a 246-by-306 
mile area around Hanford. 
Source: Hanford Environmental Dose Reconstruction 
Project (HEDR) 



































































 How the Study
Was Conducted 
> Study Group Selection 
> How Data Were Collected 
> How Data Were Analyzed 
> Consideration of Other 
Sources of Radiation 
> Native Americans and 
the HTDS 
SECTION SUMMARY 
> The HTDS studied a group of people 
from the Hanford region who were 
young children at the time of the 
largest radiation releases from 
Hanford. 
> Each participant attended a medical 
clinic for a complete diagnostic
evaluation for thyroid disease. 
> Scientists analyzed whether study 
participants with higher radiation 
doses had more thyroid disease than 
those with lower doses.
> Based on information from Native 
American Tribes and Nations, a study 
such as the HTDS in Native American 
populations alone was not feasible 
because it would have too little 
chance of detecting any health 
effects from Hanford’s iodine-131. 
STUDY GROUP SELECTION 
The HTDS study population 
represents a sampling of people 
born between 1940 and 1946 to 
mothers who lived in seven counties 
in Washington State:  Benton, 
Franklin, Adams, Walla Walla, 
Okanogan, Ferry and Stevens. 
All of the participants were 
young children at the time of the 
largest radiation releases from 
Hanford. It is believed that young 
children receive a higher dose to 
the thyroid for the same level of 
exposure than do adolescents and 
adults, and that the thyroid gland 
in young children may be more 
sensitive to the effects of radiation. 
The study participants represent a 
range of possible doses of iodine­
131 from Hanford, from the 
highest doses to very low doses. 
Starting from birth certificates of 
5,199 people born between 1940 
and 1946, investigators were able 
to locate 94 percent of the group 
(4,350 people still living and 527 
deceased). Of these, 3,440 were 
willing and able to participate fully. 
Of the 3,440 study participants, 
249 moved out of the Hanford 
region before Hanford operations 
began and did not move back into 
the region any time before the end 
of 1957. They are referred to as 
“out of area” participants in the 
HTDS. Because their thyroid 
doses could not be estimated with 
the computer models used by the 
HTDS, out of area participants 
were included in the data analyses 
as a separate group (see Figures 1-4 
in Findings and Interpretations). 
HOW DATA WERE COLLECTED 
To estimate participants’ radiation 
doses as precisely as possible, 
participants were asked to provide 
detailed information about the 
sources and amounts of foods and 
milk they consumed, and where 
they lived during the years 1944 
through 1957. The largest 
6 A Guide to the Hanford Thyroid Disease Study – Final Report
 
 How the Study
Was Conducted 
amounts of iodine-131 were 
released from Hanford during 
those years, especially in 1945. 
Of course, participants could not 
be expected to remember all the 
details of their childhood years, 
so whenever possible the 
information was obtained from 
someone with personal knowledge 
of the participant’s early life, 
often the participant’s mother.  
In addition, participants attended 
a medical clinic for a complete 
diagnostic evaluation for thyroid 
disease. At the clinic, each 
participant: 
> Completed a personal interview 
regarding his/her residential 
history, dietary history, past 
medical or occupational radiation 
exposures, and any history of 
thyroid disease. 
> Received a thyroid ultrasound 
examination. 
> Provided a blood sample to 
test for thyroid function and 
the presence of antibody 
markers for autoimmune 
thyroiditis. Serum calcium 
was also measured to test for 
hyperparathyroidism. 
> Received a physical examination 
of the thyroid by two experienced 
thyroid physicians, each 
independently of the other. 
If the person had a history of 
thyroid disease, medical records 
concerning that disease were 
also sought. 
If any thyroid abnormality was 
found, the participant was advised 
to see a health care provider for 
evaluation or treatment. 
The research team estimated each 
participant’s radiation dose to the 
thyroid. To do this, scientists used 
computer software developed under 
the Hanford Environmental Dose 
Reconstruction Project (HEDR) 
together with the information 
provided by the HTDS participants. 
HOW DATA WERE ANALYZED 
In analyzing the data, researchers 
looked for what is called a 
“dose-response.” A dose-response 
is when risk of disease increases 
with increasing dose of radiation. 
If a study finds a dose-response, it 
provides very strong evidence 
linking radiation to the disease. 
In the case of the HTDS, researchers 
studied how rates of thyroid disease 
in the study group varied in 
relation to participants’ radiation 
doses from Hanford’s iodine-131.  




HOW MANY PEOPLE PARTICIPATED IN THE HTDS? 
Total number of potential 
participants... 
5,199 — Identified from birth 
records 
4,877 — Were located 
(4,350 living,
527 deceased*) 
3,440 — Participated fully  
in the study. 
*An analysis of the underlying causes of death revealed no indication that thyroid disease or thyroid cancer 
caused any of the deaths. 
 
 How the Study
Was Conducted 
The HTDS is an “internally 
controlled study.”  This approach 
enables researchers to compare 
groups of people who have similar 
characteristics (such as age, diet, 
lifestyle or environment) but 
different levels of exposure. 
This approach of using one 
population composed of individuals 
with different levels of exposure 
has been used extensively in 
assessing the effects of radiation 
exposure in human populations. 
A less effective approach would 
be to compare the study group to 
a separate population presumed 
to be unexposed to radiation 
(“unexposed control group”). 
That approach would be less 
desirable because thyroid disease 
may be a function of a number of 
factors other than exposure to 
radiation, and those factors may 
differ considerably between 
different populations. 
Had the HTDS used an unexposed 
control group from another part 
of the country, scientists could 
not have known whether any 
differences in the rates of disease 
between the groups were due to a 
difference in exposure levels or 
some other factor. 
CONSIDERATION OF OTHER 
SOURCES OF RADIATION 
Scientists specifically designed the 
HTDS to assess the health effects 
of iodine-131 from Hanford. 
However, to be sure that any 
apparent health effects of 
Hanford’s iodine-131 were not 
actually due to other causes, 
researchers needed to consider 
other possible radiation exposures. 
For the HTDS, the research team 
considered exposures due to 
fallout from nuclear testing at the 
Nevada Test Site in the 1950s. 
They also considered exposures 
that individual study participants 
may have received from diagnostic 
or therapeutic irradiation, or 
from jobs that involved working 
with radioactive materials.  By 
explicitly accounting for such 
exposures in the analyses of the 
data, researchers were able to 
single out the effects of Hanford 
radiation. 
NATIVE AMERICANS 
AND THE HTDS   
The HTDS research team 
conducted a feasibility study to 
determine whether it would be 
possible to conduct a study like 
the HTDS of the Native American 
populations that were exposed to 
Hanford’s iodine-131.  Those 
Tribes and Nations include:  Colville, 
Couer d’Alene, Kalispell, Kootenai, 
Nez Perce, Spokane, Umatilla, 
Warm Springs and Yakama.  
A separate feasibility study was 
conducted because it was 
recognized that aspects of the 
lifestyles of Native Americans 
differed from non-Natives, 
particularly regarding diet, food 
sources and seasonal residence 
changes. All of these factors 
could have affected the dose 
people received. 
Eight of the nine tribes provided 
tribal-specific information for use 
in estimating the number of tribal 
members exposed and the likely 
magnitude of their radiation dose 
to the thyroid. Based on these 
estimates, it was determined that 
a separate study like the HTDS 
among Native Americans would 
not be feasible because it would 
have too little chance of detecting 
any health effects from Hanford’s 
iodine-131. 
Nevertheless, Native Americans 
were included in the HTDS if they 
were identified in the group of 
5,199 that made up the study 
cohort. ■ 
















> The HTDS is a scientific study 
conducted to determine whether 
there was an increased risk of
developing thyroid disease among 
people exposed to iodine-131 
from Hanford. 
> The HTDS data show that the risks of 
thyroid disease were about the same 
regardless of the radiation doses
people received. 
> The findings mean that if there is an 
increased risk of thyroid disease from 
exposure to Hanford’s iodine-131,
it is probably too small to observe 
using the best epidemiologic methods 
available. 
> Researchers found that the occurrence 
of thyroid disease in the study group 
was about the same as has been 
reported for other populations. 
STUDY OBJECTIVE 
The HTDS is an epidemiological 
study conducted to determine 
whether thyroid disease is 
increased among people who 
were exposed as young children 
to releases of iodine-131 from the 
Hanford Nuclear Site from 1944 
through 1957. 
The HTDS was designed to test 
whether the risk of thyroid disease 
in a group of people exposed to 
Hanford’s iodine-131 differed in 
relation to the radiation doses 
their thyroid glands received. 
The study cannot determine the 
cause of an individual’s disease. 
FINDINGS 
The HTDS data show that the 
risks of thyroid disease were 
about the same regardless of the 
radiation doses people received. 
In other words, no associations 
between Hanford’s iodine-131 
and thyroid disease were observed. 
The findings do not prove that 
Hanford radiation had no effect 
on the health of the area population. 
However, the findings show that 
if there is an increased risk of 
thyroid disease from exposure to 
Hanford’s iodine-131, it is probably 
too small to observe using the best 
epidemiologic methods available. 
Researchers studied all types of 
thyroid disease, as well as a disease 
of the parathyroid glands called 
hyperparathyroidism, and 
abnormalities of the thyroid 
gland that can be seen only on 
ultrasound examinations. 
In each case, the results were the 
same. The percentages of people 
with each kind of thyroid disease 
or with ultrasound abnormalities 
were about the same regardless 
of their estimated radiation dose 
from Hanford’s iodine-131. 
There were no statistically 
significant dose-responses for 
any of the diseases or ultrasound 
abnormalities studied. 
> Study Objective 
> Findings 
> How the Prevalence of 
Thyroid Disease in the HTDS 
Compares to Other 
Populations 
> How the HTDS Findings 
Compare to Other Radiation 
Studies 
> How Reliable Are the Results 
of the HTDS? 
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Thyroid disease was found in the 
study population. This was 
expected because thyroid disease 
is common in other populations, 
especially among older people 
and women. 
Researchers found that the rates 
of thyroid disease in the HTDS 
population were generally consistent 
with the rates of disease detected in 
other populations. 
Thyroid Disease 
Researchers studied all kinds of 
thyroid disease, including thyroid 
cancer (see Figure 1), benign 
thyroid nodules (see Figure 2) 
and hypothyroidism or underactive 
thyroid (see Figure 3). 
For each type of thyroid disease, 
the study found that people with 
higher doses had about the same 
amount of disease as people with 
lower doses. 
Hyperparathyroidism 
The study found no evidence that 
the risk of hyperparathyroidism 
increased with increasing radiation 
dose. This disease occurs when 
the parathyroid glands produce 
too much parathyroid hormone, 
resulting in high calcium levels in 
the body.  
However, the study did detect a 
statistically significant relationship 
between radiation dose and 
decreasing calcium levels. 
Average levels of calcium in the 
blood were slightly lower — 
though still within the normal 
range — in people with higher 
estimated thyroid radiation doses. 
Researchers have no explanation 
for the finding. Nevertheless, the 
decrease in calcium levels was so 
small that even participants with 
the highest doses had calcium 
values within the normal range. 
Non-Disease Outcomes 
The proportion of participants 
with thyroid abnormalities that 
could be seen on their ultrasound 
examinations did not increase 
significantly with increasing 
radiation dose (see Figure 4). 
Mortality in the Study Population 
Of the 5,199 people originally 
identified for inclusion in the 
   
   
  
Figure 1. OCCURRENCE OF THYROID CANCER AMONG FEMALE AND  







































































































0–9 10–49 50–99 100–199 200–399 400+ 
Thyroid radiation dose (mGy)* 
  *MilliGray (mGy) is a measure of radiation dose. 
**Out of area participants:  No dose estimate available (see page 6). 
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Findings and
Interpretations 
study, researchers found that 527 
were deceased. Researchers were 
able to locate death certificates 
for 504 of the 527 deceased 
individuals. None of the death 
certificates indicated that any 
thyroid disease, including thyroid 
cancer, was responsible for any of 
the deaths. 
Overall mortality rates in the 
study population were about the 
same as those in the state of 
Washington for the same time 
period. However, mortality rates 
for non-hereditary causes due to 
conditions that occurred before 
or shortly after birth were 
somewhat higher than those in 
the state of Washington for the 
same period. The reasons for this 
higher death rate are not known, 
though it is not likely related to 
Hanford’s iodine-131 because 
increased death rates from these 
kinds of conditions occurred even 
before the releases of iodine-131 
from Hanford began. 
HOW THE PREVALENCE OF
THYROID DISEASE IN THE 
HTDS COMPARES TO OTHER 
POPULATIONS 
People often ask how the 
occurrence of thyroid disease in 
the HTDS compares to other 
populations not exposed to 
iodine-131 from Hanford. Based 
on a descriptive analysis of the 
most comparable information 
from other studies, the HTDS 
research team found that the rates 
of thyroid disease in the study 
population are generally consistent 
with the published literature on 
other populations. In other words, 
there is no indication that the 
levels of disease in the HTDS 
population are any higher than 
what have been reported around 
the world in a variety of different 
circumstances. 
There are a number of reasons 
why a more definitive comparison 
between the HTDS population 
and other populations groups is 
not possible:
> There are no national estimates 
of thyroid diseases to which 
the HTDS can be compared.
Moreover, populations with 
different characteristics and 
different exposures may exhibit














Figure 2.   OCCURENCE OF BENIGN THYROID NODULES AMONG FEMALE AND  
                     MALE HTDS PARTICIPANTS
















































































































0% out of 
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  *MilliGray (mGy) is a measure of radiation dose. 




> Identification of thyroid disease 
in a population depends to a 
large extent on how aggressively 
one looks for the disease. For 
example, scientists are much 
more likely to detect thyroid 
nodules using ultrasound (such 
as the HTDS) than they would 
conducting a routine thyroid 
examination. 
> Physicians use different 
definitions of various thyroid 
and other conditions, making it 
difficult to compare prevalence 
of diseases in different popula­
tions. Such is the case with 
both hyperparathyroidism and 
hypothyroidism. 
> The methods used for detecting 
thyroid disease and other 
conditions have changed, 
making it difficult to compare 
studies conducted during 
different time periods. For 
example, estimates of the 
prevalence of autoimmune 
thyroiditis and thyroid nodules 
vary widely depending on the 
method of detection. 
Nevertheless, the best estimates 
of the prevalence of thyroid 
diseases, including thyroid cancer, 
in the general population are 
consistent with that found in the 
HTDS population group. 
HOW THE HTDS FINDINGS 
COMPARE TO OTHER 
RADIATION STUDIES 
No other radiation studies are 
directly comparable to the Hanford 
situation, and drawing comparisons 
with other studies is difficult 
because many factors affect thyroid 
health. Factors include the type 
of radiation (internal or external), 
the doses received, the rate at 
which the doses were received, 
how much non-radioactive iodine 
a person gets in his or her diet, 
a person’s age at the time of 
exposure, how much time has 
passed since the exposure and the 
methods researchers used to 
search for the disease. 
Nevertheless, much can be 
learned from other radiation 
studies. For example, scientists 
agree that high doses of external 
radiation, as well as high doses of 
internal radiation received in 










Figure 3.   OCCURRENCE OF HYPOTHYROIDISM AMONG FEMALE AND MALE  
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short periods of time, increase the 
risk of certain thyroid diseases. 
There is also evidence that the 
risk from radiation is greater for 
people exposed at younger ages. 
Much less is known about 
situations such as Hanford, 
where populations are exposed to 
lower levels of internal radiation 
from iodine-131 over prolonged 
periods of time.  
The following is a review of other 
important radiation studies. 
(Refer to the chart on page 14.) 
External Exposures 
Studies of survivors of the atomic 
bombings of Hiroshima and 
Nagasaki during World War II 
show that people exposed to high 
levels of external gamma radiation 
face an increased risk of thyroid 
cancer.  People whose thyroid 
glands were exposed in childhood 
to high levels of external 
radiation from x-ray treatments 
of the head and neck are also at 
increased risk. (Medical uses of 
x-ray treatments of children have 
changed since the 1960s.) 
What distinguishes these situations 
from Hanford is that the exposures 
were external and not from 
iodine-131, the radiation doses 
were much higher and the doses 
were delivered in very short 
periods of time. 




Studies show that children and 
adults exposed to internal and 
external radiation from nuclear 
testing in the Marshall Islands 
(largest test in 1954) have an 
increased risk of thyroid nodules. 
Other studies show a large 
increase in thyroid cancer among 
children exposed to iodine-131 
and other radiation from 
Chernobyl in 1986. 
Neither situation is directly 
comparable to Hanford because 
the radiation received in both 
instances was a mixture of 
internal and external exposures, 
and the doses were higher and 
delivered over shorter periods of 
time. In the case of Chernobyl, 
iodine deficiency in the population 













   
 
Figure 4.   OCCURRENCE OF ULTRASOUND-DETECTED THYROID ABNORMALITIES  
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> Exposure to x-ray treatment. 
> Exposure lasted seconds 
to minutes. 
> Studied exposure in 
childhood. 
> Exposure resulted in 
increased risk of thyroid 
cancer. 
HIROSHIMA AND NAGASAKI 
> Exposure primarily to 
gamma rays; some neutron 
exposure. 
> Exposure lasted seconds. 
> Studied exposure at all ages. 
> Exposure resulted in 
increased risk of thyroid 
cancer, with greatest risk 
in children; limited evidence 
of an increased risk of 
autoimmune thyroiditis. 
MIX OF INTERNAL AND EXTERNAL EXPOSURES 
MARSHALL ISLANDS 
> Exposure to iodine-131 
plus other internal and 
external radionuclides. 
> Exposure lasted weeks. 
> Studied exposure at all 
ages. 
> Exposure resulted in 
increased risk of 
thyroid nodules and 
hypothyroidism, 
primarily in children. 
CHERNOBYL 
> Exposure to iodine-131 
plus other internal and 
external radionuclides. 
> Exposure lasted days to 
weeks. 
> Studied exposure in 
childhood. 
> Exposure resulted in 
large increased risk 
of thyroid cancer in 
children.  Iodine deficiency 
in the diet may also be a 
contributing factor. 
NEVADA TEST SITE 
> Exposure to iodine-131 plus other internal 
and external radionuclides. 
> Exposure lasted weeks to months. 
> Studied exposure in children. 
> Exposure resulted in increased risk of 
thyroid nodules; some indication of an 
increased risk of thyroid cancer. 
INTERNAL EXPOSURES 
MEDICAL USES OF IODINE-131 
FOR TREATMENT 
> Exposure to iodine-131. 
> Exposure lasted days to weeks. 
> Studied exposure at all ages, 
primarily adults. 
> Exposure resulted in increased risk 
of hypothyroidism (intent of the 
treatment); no clear evidence of an 
increased risk of thyroid cancer 
from iodine-131 exposure. 
MEDICAL USES OF IODINE-131 
FOR DIAGNOSIS 
> Exposure to iodine-131. 
> Exposure lasted days to weeks. 
> Studied exposure at all ages, 
primarily adults. 
> Exposure not associated with an 
increased risk of thyroid cancer. 
HANFORD 
> Exposure almost entirely to 
iodine-131. 
> Exposure lasted months to years. 
> Studied exposure in children. 
> Exposure not associated with an 




may also be a factor in the rate of 
thyroid disease. 
A study of people exposed as 
children to fallout from nuclear 
testing in the 1950s at the 
Nevada Test Site is called the 
Utah Study.  This study found an 
increased risk of thyroid neoplasia, 
which is a category of disease 
that the researchers defined to 
include both thyroid cancer and 
certain kinds of benign nodules. 
However, there was no clear 
evidence that the risk of thyroid 
cancer alone was increased. 
The study is considered the most 
comparable to the Hanford 
situation, but there are important 
differences. While exposure was 
largely from iodine-131, it also 
likely included short-lived radio­
active iodines as well as external 
radiation. In addition, the Utah 
exposures were concentrated over 
shorter time periods. 
Internal Exposures 
There have been epidemiological 
studies of the effect of iodine-131 
alone. However, these have all 
been based on people who received 
iodine-131 to treat thyroid 
disease, or to diagnose suspected 
thyroid disease. People exposed 
to radioactive iodine for medical 
reasons (primarily for the treatment 
of Graves disease) generally 
received very high doses. While 
several studies found an increased 
risk of thyroid cancer, the 
researchers concluded this was 
likely due to the patients’ 
underlying thyroid diseases, not 
their iodine-131 exposures. 
People exposed to radioactive 
iodine for diagnostic purposes 
received much lower doses. Studies 
have not found an increased risk 
of thyroid cancer associated with 
diagnostic exposures. 
HOW RELIABLE ARE THE 
RESULTS OF THE HTDS? 
An important consideration in 
any epidemiological study is the 
reliability of the information. In 
the case of HTDS, researchers 
could be confident that their 
assessments of thyroid disease 
were very reliable because 
participants received thorough 
examinations of their thyroid 
glands by experienced doctors. 
On the other hand, estimating 
radiation doses to the participants’ 
thyroid glands was inherently 
uncertain. This is because their 
doses depended not only on 
where they lived, but also on the 
quantities and sources of the food 
and milk products they consumed 
when they were infants and 
young children during 1944 
through 1957. Highly accurate 
recollection of information from 
so long ago is simply not possible. 
In addition, the amounts of 
iodine-131 released from Hanford, 
and how that iodine-131 moved 
through the environment, are not 
known exactly. 
In order to account for the effects 
of this uncertainty about the 
participants’ doses, HTDS 
researchers performed special 
statistical analyses. They also 
examined whether risks of thyroid 
diseases and thyroid ultrasound 
abnormalities differed according 
to where the participants lived 
and/or how much milk they 
consumed, rather than their 
estimated doses. None of these 
additional analyses led to a 
conclusion that risks of thyroid 
disease increased with increasing 
exposure to Hanford’s iodine-131. 
No epidemiological study can 
state with absolute certainty 
whether or not an exposure (such 
as Hanford’s iodine-131) has 
affected people’s health. 
Nevertheless, studies such as the 
HTDS can be conducted in ways, 
and with enough participants, to 
provide confidence that if an 
association exists it is likely 
small. In the HTDS, scientists did 
not observe an association using a 
careful study design, thorough 
clinical evaluation, and several 
alternative approaches for 
estimating radiation dose and 
analyzing study data. ■ 






















Hanford Thyroid Disease 
Study Timeline 
1986 and 1987 
U.S. Department of Energy (DOE) releases 
classified documents describing radiation 
releases at Hanford. 
1986 
CDC forms an independent panel of
 
scientists (Hanford Health Effects Review
 
Panel) to evaluate DOE documents.
 
Hanford Health Effects Review Panel 

recommends two studies:  1) to estimate
 
radiation doses received by area residents
 
(which became known as the Hanford
 
Environmental Dose Reconstruction Project
 
(HEDR)), 2) to examine the feasibility of
 
studying the potential health effects of
 
iodine-131 among exposed populations
 
(which led to the HTDS).   

CDC forms second independent panel
 
(Hanford Historical Documents Review
 





Battelle Pacific Northwest Laboratories 
begins work on HEDR under DOE contract.  
1988 
DOE forms Technical Steering Panel 

of scientists, representatives of
 
Native American Tribes and community
 
representatives to oversee HEDR.
 
Congress directs CDC to conduct 

a study of thyroid disease in 

the area around Hanford.
 
1989 
CDC awards contract to
 
Fred Hutchinson Cancer Research Center
 
for HTDS.  Work begins on HTDS 

protocol and pilot study.

1990 
HTDS scientists begin public 
communications with public
meetings, mailings, newsletters 
and toll-free number. 
U.S. Department of Health and Human 
Services appoints HTDS Advisory 
Committee (scientists, public health
officials, public and Native American 
representatives) to advise CDC on design 
and implementation of HTDS.
HTDS scientists hold public meetings
in Northwest to solicit comments from
the public and scientists on pilot study 
design and protocol.  
1991 
HTDS Advisory Committee
meetings begin on a regular basis.  
All meetings open to the public. 
1992 
HTDS pilot study design and protocol
 
approved by the Federal Office
 
of Management and Budget and 

the Institutional Review Board of
 
Fred Hutchinson Cancer Research Center.
 
1986 – 1987 1990 1993 – 1994 
1988 – 1989 1991 – 1992 
1993 
HEDR funding transferred from DOE to CDC. 
1994 
HEDR final reports published. 


























HTDS Pilot Study Report issued.  Full 
epidemiologic study determined feasible. 
National Academy of Sciences 
conducts peer review of HTDS Pilot 
Study Report and finds study design 
to be sound science. 
HTDS Advisory Committee reviews 
pilot study results and recommends
proceeding to full epidemiologic study. 
National Academy of Sciences conducts
 
peer review of HTDS Analysis Plan 













1995 1998 2000 – 2002 
1997 1999 
Fred Hutchinson Cancer Research Center
 
completes HTDS Draft Report.  

CDC scientists evaluate report.  

CDC convenes ad hoc review group of
 
independent scientists who provide written
 
reviews and opinions on HTDS Draft Report.  

CDC and Fred Hutchinson Cancer Research
 
Center release HTDS Draft Report for 

purpose of scientific peer review
 
and public comment.  CDC and HTDS 

scientists hold public meeting in Richland
 
to review draft findings. 

CDC holds five-month public comment 

period on HTDS Draft Report.
 
National Academy of Sciences
 
conducts peer review of HTDS Draft Report.
 
NAS holds public meeting in Spokane.
 
2000 
National Academy of Sciences issues its
 




2000 – 2002 
CDC and Fred Hutchinson Cancer Research 
Center conduct additional technical work 
based on National Academy of Sciences
recommendations, and comments from 
independent scientists and the public. 
2001 
CDC conducts audience research to
prepare for communication of HTDS Final 
Report.   Research includes discussion 
groups with HTDS participants, Hanford 
public, and local government and public 
interest group representatives. 
2002 
CDC and Fred Hutchinson Cancer Research
 
Center release the HTDS Final Report.
 











and Scientific Review 
> Reviewers and Their Roles 
> Review Process 
SECTION SUMMARY 
> The public commented on design and 
implementation issues throughout 
the study. 
> The HTDS Advisory Committee
provided ongoing advice to CDC on 
the design and implementation of the 
study. 
> A committee of the National Academy 
of Sciences peer reviewed the HTDS 
at three points:  Pilot Study, Analysis 
Plan and HTDS Draft Report. 
> CDC convened other independent 
scientists to review the HTDS Draft 
Report. 
REVIEWERS AND THEIR ROLES 
Throughout the study, HTDS 
researchers received input and 
suggestions from a wide variety 
of sources. 
The Public 
Individuals and public groups 
provided input in a variety of 
ways, including participation in 
public meetings and the HTDS 
Advisory Committee, and with 
written comments to CDC. 
The research team communicated 
with the public throughout the 
study using newsletters, mailers 
and a toll-free number.  Under a 
separate project funded by the 
Federal Government, the 
Hanford Health Information 
Network provided information 
about radiation health effects. 
The HTDS Advisory Committee 
The HTDS Advisory Committee 
(officially known as the Hanford 
Thyroid Morbidity Study Advisory 
Committee) was created to 
advise CDC on the design and 
implementation of the study.
The committee was chartered by 
the U.S. Department of Health 
and Human Services. Scientists, 
state health officials, environmental 
groups, Indian Nations and the 
public were represented in the 
group. 
The committee met regularly from 
1991 through 1999. At each 
meeting the public was given an 
opportunity to ask questions and 
offer their own views on the study. 
National Academy of
Sciences (NAS) 
The NAS is one of the country’s 
most respected scientific 
organizations. At three points in 
the study (Pilot Study, Analysis 
Plan and HTDS Draft Report), an 
NAS committee peer reviewed the 
study and made recommendations 
to the research team. The NAS 
committee included epidemiologists, 
statisticians and other scientists. 
Peer review is an independent 
scientific evaluation that helps 
ensure that a study is of high 
quality. 




and Scientific Review 
Independent Scientists 
In 1998, CDC convened a group 
of independent scientists with 
expertise in thyroid disease, 
radiation and epidemiology to 
review the HTDS Draft Report. 
Their evaluation was made available 
in a public report. 
Other independent scientists offered 
critical review on the pilot study 
design and protocol during the 
early phase of the study.  
REVIEW PROCESS 
The HTDS involved extensive 
scientific peer review and public 
involvement. 
Study Design 
The study design, or protocol, 
describes all the methods used for 
conducting the study, such as 
recruiting participants and 
conducting thyroid examinations. 
Public interest groups, scientists 
and members of the public were 
invited to comment on the protocol 
in public meetings in the Northwest. 
They were also encouraged to 
send written comments to CDC. 
The protocol was evaluated by 
the HTDS Advisory Committee, 
and approved by CDC, the 
Institutional Review Board of the 
Fred Hutchinson Cancer Research 
Center and the Federal Office of 
Management and Budget. 
Pilot Study 
In the early 1990s, researchers 
began recruiting participants and 
collecting data for a pilot study 
to determine the feasibility of a 
large-scale epidemiologic study. 
A Pilot Study Report was issued 
in 1994, peer reviewed by the 
NAS, and approved by the HTDS 
Advisory Committee. In 1995, 
both panels agreed that a full-scale 
epidemiologic study was feasible. 
The NAS also recommended that 
the researchers develop an analysis 
plan describing how the data 
would be analyzed. 
Analysis Plan 
The Analysis Plan was completed 
in 1997 and peer reviewed by the 
NAS. It was also reviewed and 
approved by the HTDS Advisory 
Committee. In addition, the public 
was invited to offer its own views 
on the plan. 
HTDS Draft Report 
CDC released the HTDS Draft 
Report in January 1999. An 
extensive review by the NAS 
concluded that the study was 
scientifically sound but had probably 
overstated the certainty of the 
findings. The NAS recommended 
a number of technical revisions 
and clarifications. 
Following the review, the research 
team conducted additional technical 
work to address the NAS 
recommendations as well as those 
received from the public and 
other independent scientists. The 
HTDS Final Report represents 
completion of the study. ■ 










THE REVIEWERS AND THEIR ROLES 





Participated in Advised CDC 
public meetings on design and 
and provided implementation 
written comments issues from
to CDC throughout 1991 through 







Conducted Reviewed various 
scientific peer aspects of the
reviews in 1995, science











> A Look at Thyroid Disorders 
> Checking for Thyroid Disease 
> Treatment of Thyroid Disease 
> Recommendation for Thyroid 
Check-ups 
SECTION SUMMARY 
> Thyroid disease is common, especially 
among older people and women.
> Checking for thyroid disease involves 
an evaluation of the thyroid by an 
experienced doctor. 
> If you are concerned about exposure 
to iodine-131 from Hanford or
experience thyroid disease symptoms, 
you should see your doctor for a 
thyroid evaluation. 
A LOOK AT THYROID DISORDERS 
The thyroid gland, located in the 
front of the neck just below the 
Adam’s apple, takes iodine from 
the diet and makes thyroid 
hormone. Thyroid hormone 
affects a person’s physical energy, 
temperature, weight and mood. 
Thyroid diseases generally fall 
into two broad groups of disorders: 
abnormal function and abnormal 
growth (nodules) in the gland. 
These problems are common in 
the general population, especially 
among older people and women. 
Most thyroid problems can be 
detected and treated. 
Functional disorders are usually 
related to the gland producing 
too little thyroid hormone 
(hypothyroidism) or too much 
thyroid hormone (hyperthyroidism). 
Benign nodules in the thyroid 
gland are common and do not 
usually cause serious health 
problems. These nodules occur 
when the cell growth within the 
nodule is abnormal.  Nodules can 
occasionally put pressure on the 
neck and cause trouble with 
swallowing, breathing or speaking 
if they are too large. The thyroid 
usually functions normally even 
when nodules are present. 
Thyroid cancers are much less 
common than benign nodules. 
With treatment, the cure rate 
for thyroid cancer is more than 
90 percent. 
CHECKING FOR THYROID DISEASE 
Checking for thyroid disease is 
similar to other kinds of medical 
evaluations. The doctor considers 
the patient’s medical history, 
examines the thyroid and may 
order a blood test or other 
diagnostic tests. 
A standard physical examination 
of the thyroid gland is done by 
palpation — that is, feeling the 
thyroid gland. The doctor feels 
for the size and texture of the 
gland, and whether any masses 
or nodules are present. 
Testing for Thyroid Function 
There are two standard blood 
tests of thyroid function: 
the measurement of thyroid 
hormone, usually T4, and the 
measurement of thyrotropin 










(TSH). TSH is a hormone 
secreted from the pituitary gland 
that controls how much thyroid 
hormone the thyroid makes. 
Abnormal blood tests usually 
reveal thyroid function problems 
and not the presence of thyroid 
nodules or cancer. 
Testing for Nodules 
If a nodule is found during the 
physical examination, a test 
called fine needle aspiration 
(FNA) biopsy may be done to 
help find out whether the nodule 
is cancerous or benign. In addition, 
a thyroid nuclear scan may help 
the doctor evaluate thyroid 
function or nodules. The scan is 
performed by giving the patient a 
radioisotope and taking a special 
picture to see how much of the 
radioisotope is taken up by the 
thyroid gland. 
A thyroid ultrasound scan is a 
diagnostic test that shows a picture 
of the anatomy, or structure, of 
the thyroid gland. Ultrasound is 
most often used to determine if a 
nodule is solid or cystic. Cystic 
nodules, containing only fluid, 
are usually benign. 
Ultrasound is not usually performed 
as a routine screening test for 
thyroid nodules in the general 
population. The reason is that 
small, nonpalpable ultrasound 
abnormalities are very common 




The treatment of thyroid disease 
depends on many factors, including 
the type and severity of the thyroid 
disorder and the age and overall 
health of the patient. Treatment 
must be specific to each individual. 
> Thyroid cancer is initially treated 
with thyroid surgery.  Many 
patients also receive further 
treatment with iodine-131. 
Patients treated for thyroid 
cancer require lifelong thyroid 
hormone replacement. 
SYMPTOMS OF ABNORMAL THYROID FUNCTION 
TOO LITTLE THYROID HORMONE 
(HYPOTHYROIDISM) 
> Depression or feeling blue 
> Trouble concentrating 
> Tiredness 
> Dry skin and hair 
> Weight gain 
> Feeling cold all the time 
TOO MUCH THYROID HORMONE 
(HYPERTHYROIDISM) 
> Nervousness and anxiety 
> Weight loss
> Tremor (shaking) 
> Fast, irregular pulse 
> Tiredness 
> Feeling hot all the time 
> The majority of benign nodules 
do not require treatment. 
Patients with benign nodules 
are usually advised to have 
periodic follow-up 
examinations. 
> Hypothyroidism usually requires 
only replacement of thyroid 
hormone by taking a single 
daily tablet at a dose adjusted 
to produce normal thyroid 
hormone levels. 
> Autoimmune thyroiditis is a 
disorder that may cause 
hypothyroidism. It usually 
does not cause symptoms that 
require treatment unless 
hypothyroidism develops. In 
such cases, thyroid hormone 
replacement is required. 
> Treatment of hyperthyroidism 
may include antithyroid drugs, 
radioactive iodine-131 or in 
rare cases, thyroid surgery.
RECOMMENDATION FOR 
THYROID CHECK-UPS 
If you have received regular health 
care and have no symptoms of 
thyroid disease, you may not need 
to see a doctor to check for 
thyroid disease. However, if you 
are concerned about being exposed 
to iodine-131 from Hanford 
or experience thyroid disease 
symptoms, you should see 
your doctor for a thyroid 
examination. ■ 

















Information about the Hanford 
Thyroid Disease Study and 
related topics is available 
through the Centers for Disease 
Control and Prevention (CDC) 
and other agencies in the U.S. 
Department of Health and 
Human Services. 
CENTERS FOR DISEASE 
CONTROL AND PREVENTION 
Hanford Thyroid Disease Study 
> Write to 
Hanford Thyroid Disease Study 
Centers for Disease Control 
and Prevention 













> HTDS Web Site 
The HTDS Final Report and public 
information materials are 
available at http://www.cdc.gov/ 
nceh/radiation 
> Public Libraries 
The HTDS Final Report can be 
viewed at the following libraries 
beginning July 2002: 
– 	University of Washington Health 
Sciences Library, Seattle, WA 
– Seattle Public Library System, 
Seattle, WA 




– Gonzaga University Library 




– Richland Library, Richland, WA 
– DOE Reading Room, Richland, WA 
AGENCY FOR TOXIC SUBSTANCES 
AND DISEASE REGISTRY 
The Hanford Community Health 
Project provides a variety of
public health materials related to 
iodine-131 for individuals exposed 
as young children to releases of 
iodine-131 from Hanford from 1945 
through 1951.  The Project is 
sponsored by the Agency for 
Toxic Substances and Disease 
Registry (ATSDR).  
For more information: 
Hanford Community Health Project      
800-207-3996      
Hanford@norcmail.uchicago.edu          
or 
ATSDR Information Center 
888-42ATSDR (888-422-8737) 
ATSDRIC@cdc.gov 
NATIONAL CANCER INSTITUTE 
The National Cancer Institute has 
materials on thyroid cancer and 
screening, and iodine-131 exposure. 

























THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) 
CDC protects people’s health and safety by preventing and controlling diseases 
and injuries, providing information on health issues, and promoting healthy living 
through partnerships with local, national and international organizations. 
Paul Garbe, D.V.M., M.P.H. 
Scientific Advisor, HTDS; Associate Director for Science, Division of 
Environmental Hazards and Health Effects, National Center of Environmental 
Health 
Dr. Garbe has worked at CDC for 20 years on issues related to the health effects 
of environmental hazards.  He served in CDC’s Epidemic Intelligence Service, and 
since 1991, has coordinated CDC epidemiology projects which assess relationships 
between thyroid diseases and environmental radiation exposures. 
Mike Donnelly 
HTDS Project Manager 
Mike Donnelly was CDC’s HTDS project officer through 2001 and has been 
involved in Hanford issues since 1991.  He has more than 20 years experience 
with CDC as a public health advisor working on a variety of public health issues. 
The HTDS was conducted by
a team of scientists and 
physicians with extensive
experience in epidemiological 
research, radiation exposure 
and thyroid disease. 
FRED HUTCHINSON CANCER RESEARCH CENTER  (FHCRC) 
The Fred Hutchinson Cancer Research Center is an independent, non-profit research institution, which conducts scientific 
investigations of the causes and treatments of cancer and other potentially fatal diseases.
Scott Davis, Ph.D. Kenneth J. Kopecky, Ph.D. Thomas Hamilton, M.D., Ph.D. 
Principal Investigator, HTDS; Co-investigator, HTDS; Program in Co-investigator, HTDS; Clinical 
Program in Epidemiology, FHCRC; Biostatistics, FHCRC; Affiliate Associate Professor, Division of 
Professor and Chairman, Professor, Department of Endocrinology and Metabolism, 
Department of Epidemiology, School Biostatistics, School of Public Health University of Washington 
of Public Health and Community 
Medicine, University of Washington 
and Community Medicine, University 
of Washington 
Dr. Hamilton is a practicing
endocrinologist and an expert in the 
Dr. Davis’ research is focused on Dr. Kopecky is a biostatistician with diagnosis and management of
investigations of the health effects extensive experience in research into thyroid disease.  He has conducted 
of radiation exposure in human the health effects of radiation, research in the Marshall Islands, 
populations, and includes studies including studies of Japanese atomic where he evaluated the risk of
of survivors of the atomic bombings bomb survivors and of people thyroid disease among people 
in Japan and people exposed to exposed to fallout from Chernobyl. exposed to fallout from nuclear 
radiation from Chernobyl. Dr. Kopecky also served as a member weapons testing. 
of the HEDR Technical Steering Panel. 
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